SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-038760
Filing Date
2019-08-09
Accepted
2019-08-09 11:19:43
Documents
53
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv526697_10q.htm 10-Q 378879
2 EXHIBIT 31.1 tv526697_31-1.htm EX-31.1 10357
3 EXHIBIT 31.2 tv526697_31-2.htm EX-31.2 10613
4 EXHIBIT 32.1 tv526697_32-1.htm EX-32.1 4636
5 EXHIBIT 99.1 tv526697_99-1.htm EX-99.1 56673
12 GRAPHIC tv526697_img01.jpg GRAPHIC 29129
13 GRAPHIC image_001.gif GRAPHIC 1647
  Complete submission text file 0001144204-19-038760.txt   3415734

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fencf-20190630.xml EX-101.INS 923281
7 XBRL TAXONOMY EXTENSION SCHEMA fencf-20190630.xsd EX-101.SCH 31637
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fencf-20190630_cal.xml EX-101.CAL 24014
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fencf-20190630_def.xml EX-101.DEF 97787
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20190630_lab.xml EX-101.LAB 209913
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20190630_pre.xml EX-101.PRE 187793
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 191011912
SIC: 2836 Biological Products, (No Diagnostic Substances)